🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the Emergency Department (ED), diabetes is commonly encountered as a sec...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00663624
Treatments Being Tested
Primary Objective: Evaluate the percentage of patients achieving glycosyla...
Status
Completed
Location
Administrative office
Start Date
2011-05
Trial ID
NCT01202474
Treatments Being Tested
Primary Objective: To compare the efficacy of insulin glargine (U300) and ...
Status
Completed
Location
Investigational Site Number 1560039
Start Date
2016-08-24
Trial ID
NCT02855684
Treatments Being Tested
The study is a multicenter, prospective, open-label, randomized pilot study...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2011-08
Trial ID
NCT01378117
Treatments Being Tested
This study compares insulin 287 (a possible new medicine) to insulin glargi...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-09
Trial ID
NCT03922750
Treatments Being Tested
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
The study will look at the efficacy and safety of NNC0268-0965 (referred to...
Status
Completed
Location
Profil GmbH & Co. KG
Start Date
2020-10-21
Trial ID
NCT04575181
Treatments Being Tested
Primary Objective: 6 To assess the efficacy of insulin glargine given once...
Status
Completed
Location
Investigational Site Number 156006
Start Date
2011-02
Trial ID
NCT01223131
Treatments Being Tested
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
Primary Objective: To demonstrate equivalence in exposure to insulin glarg...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2013-04
Trial ID
NCT01838083
Treatments Being Tested